JasonRobertStubbsMD
Nephrology • Kansas City, KSAssociate Professor, Internal Medicine, University Kansas School of Medicine
Dr. Stubbs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3901 Rainbow Blvd
Ms3002
Kansas City, KS 66160Phone+1 913-588-6074Fax+1 913-588-3867- Is this information wrong?
Education & Training
University of Kansas School of MedicineFellowship, Nephrology, 2005 - 2007- University of Kansas School of MedicineResidency, Internal Medicine, 2002 - 2005
- University of Kansas School of MedicineClass of 2002
Certifications & Licensure
MO State Medical License 2021 - 2025
KS State Medical License 2005 - 2024
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease Start of enrollment: 2008 May 01
- Impact of Vitamin D Therapies on Chronic Kidney Disease Start of enrollment: 2010 Oct 01
- Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- Correction of Vascular Calcification and Hyperphosphatemia in CKD Rats Treated with ASARM Peptide.Peter S Rowe, Ellen M McCarthy, Alan L Yu, Jason R Stubbs> ;Kidney360. 2022 Oct 27
- 2 citationsCritical Role of Osteopontin in Maintaining Urinary Phosphate Solubility in CKD.Jason R Stubbs, Shiqin Zhang, Kyle P Jansson, Timothy A Fields, Joseph Boulanger, Shiguang Liu, Peter S Rowe> ;Kidney360. 2022 Sep 29
- Response to "Fibroblast Growth Factor 23 Is a Valuable Predictor of Autosomal Dominant Polycystic Kidney Disease Progression".Alan S.L. Yu, Mireille El Ters, Jason R. Stubbs> ;Kidney International Reports. 2021 Mar 27
- Join now to see all
Lectures
- Kidney, Bone, and Vasculature: Is the Gut a New Piece of the Puzzle?American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
Other
- Overview of the causes and treatment of hyperphosphatemiaStubbs JR, Yu AS
http://www.uptodate.com/contents/overview-of-the-causes-and-treatment-of-hyperphosphatemia
UpToDate, Wolters Kluwer Health - 2013-03-04
Press Mentions
TMAO Implicated as a Cardiovascular Risk Factor in CKDAugust 5th, 2015
Grant Support
- Exploring The Interrelationships Of Mineral Metabolism Pathways In Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Clinical Trial: Extrarenal 1-Alpha-Hydroxylase In End-Stage Renal DiseaseNational Center For Research Resources2009
Hospital Affiliations
The University of Kansas HospitalKansas City, Kansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
